Clinical Efficacy of Sedative Cataplasm for Insomnia Patients with Sub-health  

作　　者：Xiaoxue GONG Qin GONG Xi WANG 

机构地区：[1]Shiyan Hospital of Traditional Chinese Medicine, Shiyan 442000, China [2]Shiyan Taihe Hospital/Affiliated Hospital of Hubei University of Medicine, Shiyan 442000, China

出　　处：《Medicinal Plant》2021年第2期67-69,共3页药用植物：英文版

基　　金：Science and Technology Research and Development Project of Shiyan City(16Y76).

摘　　要：[Objectives]This study aimed to observe the clinical efficacy of sedative cataplasm in the treatment of insomnia patients with sub-health.[Methods]A total of 90 insomnia patients with sub-health were randomly and evenly divided into treatment group and control group.The patients in the control group were given Bozi Yangxin pills orally,and those in the treatment group were treated with sedative cataplasm on Shenjue acupoint.The treatment duration was 4 weeks.The Pittsburgh Sleep Quality Index(PSQI)was used to evaluate clinical efficacy.[Results]The overall efficacy of the treatment group and control group was 91.1%and 77.1%,respectively,and the difference between the two was significant(P<0.05).After treatment,the PSQI scores of each group changed significantly(P<0.05).[Conclusions]Sedative cataplasm has a good clinical efficacy on sub-healthy insomnia patients.

关 键 词：SUB-HEALTH INSOMNIA Sedative cataplasm Clinical observation 

分 类 号：R73[医药卫生—肿瘤]